ArticleMolecular cancer therapeutics2017

Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer.

Jie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.